These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31193785)

  • 21. Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy.
    Pan M; Li W; Yang J; Li Z; Zhao J; Xiao Y; Xing Y; Zhang X; Ju W
    Medicine (Baltimore); 2017 Jul; 96(30):e7405. PubMed ID: 28746182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides.
    Nunes R; Araújo F; Barreiros L; Bártolo I; Segundo MA; Taveira N; Sarmento B; das Neves J
    ACS Appl Mater Interfaces; 2018 Oct; 10(41):34942-34953. PubMed ID: 30234288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ
    Amin FU; Shah SA; Badshah H; Khan M; Kim MO
    J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy.
    Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z
    Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model.
    Li Z; Wu X; Li J; Yao L; Sun L; Shi Y; Zhang W; Lin J; Liang D; Li Y
    Int J Nanomedicine; 2012; 7():2389-98. PubMed ID: 22661892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
    Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel PLGA-based nanoparticles for the oral delivery of insulin.
    Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
    Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
    Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
    Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective role of poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol against isoproterenol-induced myocardial infarction.
    Sun L; Hu Y; Mishra A; Sreeharsha N; Moktan JB; Kumar P; Wang L
    Biofactors; 2020 May; 46(3):421-431. PubMed ID: 31926035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis.
    Qin X; Xu Y; Zhou X; Gong T; Zhang ZR; Fu Y
    Acta Pharm Sin B; 2021 Mar; 11(3):835-847. PubMed ID: 33777685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
    Li S; Wang A; Jiang W; Guan Z
    BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of PEG-PLGA-PEG nanoparticles-based multipolyplexes for IL-18 gene delivery.
    Nie Y; Zhang ZR; He B; Gu Z
    J Biomater Appl; 2012 May; 26(8):893-916. PubMed ID: 21273262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
    Liu D; Zhang W; Liu X; Qiu R
    Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correct Identification of the Core-Shell Structure of Cell Membrane-Coated Polymeric Nanoparticles.
    Liu L; Yu W; Seitsonen J; Xu W; Lehto VP
    Chemistry; 2022 Dec; 28(68):e202200947. PubMed ID: 36116117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.